Cover image not available

Infliximab (review) and adalimumab for the treatment of Crohn's disease (including a review of technology appraisal guidance 40)

National Institute for Health and Clinical Excellence

Publication Data

Title Infliximab (review) and adalimumab for the treatment of Crohn's disease (including a review of technology appraisal guidance 40)
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Descriptive Notes

Issue date: May 2010 ; Review date: September 2011.
"This guidance replaces 'NICE technology appraisal guidance 40' issued in April 2002."
"The guidance was developed using the NICE multiple technology appraisal process."
Publisher's number: N2157.

Topics

Crohn's disease :: Chemotherapy
Infliximab
Monoclonal antibodies

Catalogue Data

OBNB ID GBB586247
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.344061

ISBD

P1053 1 online resource (2 unnumbered pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Infliximab (review) and adalimumab for the treatment of Crohn's disease (including a review of technology appraisal guidance 40) by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.